Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Life Virgin Islands.
Press releases published on July 9, 2025
BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference
GlobeNewswire
·
July 9, 2025
CARSON CITY, Nev., July 09, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
GlobeNewswire
·
July 9, 2025
WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …
FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions
GlobeNewswire
·
July 9, 2025
WALTHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced two presentations at recent medical meetings: the 20th World Congress of the International Pancreas …
zSpace Imagine Wins Future’s Best of Show Award at ISTELive25, Presented by Tech & Learning
GlobeNewswire
·
July 9, 2025
SAN JOSE, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- zSpace (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leader in immersive learning, announced today that the Company is a recipient of Future’s Best of Show Award, presented at ISTE 2025 by Tech …
‘Lavender & The Butterfly Nation’ Pushes Boundaries with World’s First GenAI-Hybrid Animated Feature
GlobeNewswire
·
July 9, 2025
LONDON, July 09, 2025 (GLOBE NEWSWIRE) -- IMAGENai Inc., a boundary-pushing GenAI creative studio, unveils its pioneering animated feature, Lavender …
Amneal to Report Second Quarter 2025 Results on August 5, 2025
GlobeNewswire
·
July 9, 2025
BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial results on …
Introducing Aptean Fresh Produce ERP: The Next-Generation of Produce Pro Software
GlobeNewswire
·
July 9, 2025
Unifying Decades of Fresh Produce Expertise with Cutting-Edge Technology in a Powerful, Cloud-Based ERP Solution ALPHARETTA, Ga., July 09, 2025 (GLOBE NEWSWIRE) -- Aptean, a global leader in mission-critical enterprise software solutions, announces the …
CoRegen, Inc. Closes More Than $93 Million Financing
GlobeNewswire
·
July 9, 2025
HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the close of a $93,390,000 million financing. The proceeds …
Magnite to Announce Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 9, 2025
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Wednesday, August 6, 2025. …
Benitec Biopharma Provides Operational Updates
GlobeNewswire
·
July 9, 2025
-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)- -Independent Data Safety Monitoring Board Review Has Been Completed for All Six Subjects …
‘Lavender & The Butterfly Nation’ Breaks Ground as World’s First GenAI-Hybrid Animated Feature Blending AI with Human Emotion
GlobeNewswire
·
July 9, 2025
HOLLYWOOD, July 09, 2025 (GLOBE NEWSWIRE) -- IMAGENai Inc., a visionary GenAI creative studio, introduces “Lavender …
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
GlobeNewswire
·
July 9, 2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc., a late-stage clinical biopharmaceutical company developing covalently bonded dimer therapeutics, today announced the appointment of Sergio Traversa, PharmD, as an Independent Director to its …
OrangeKloud signs Contract for the Supply and Implementation of Cloud Workspace Terminals
GlobeNewswire
·
July 9, 2025
SINGAPORE, July 09, 2025 (GLOBE NEWSWIRE) -- OrangeKloud Technology Inc. (Nasdaq: ORKT) (“OrangeKloud” or “the Company”), a Singapore-based technology company offering the eMOBIQ® No-Code platform for development of mobile applications, is pleased to …
Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib
GlobeNewswire
·
July 9, 2025
- Newly issued U.S. composition of matter patent expected to provide exclusivity into 2042, with subsequent opportunity for patent term extension - - First U.S. patent granted on a deep cyclic inhibitor: a once-daily pill that aims to drive longer-lasting …
Layer Raises $6.6M Led by Emergence Capital to Bring Embedded Accounting to the SMB Software Stack
GlobeNewswire
·
July 9, 2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- Layer, the leading embedded accounting platform for small and medium-size business (SMB) software, today announced it has raised $6.6 million in seed funding led by Emergence Capital, with participation from …
Finding certainty in market turmoil: Why more and more investors choose SAVVY MINING
GlobeNewswire
·
July 9, 2025
London, UK, July 09, 2025 (GLOBE NEWSWIRE) -- With Solana (SOL) continuing to expand in the blockchain field, Ripple (XRP) being widely used in cross-border payments in Asia, and Dogecoin (DOGE) regaining the attention of retail investors, the enthusiasm …
Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity
GlobeNewswire
·
July 9, 2025
-- Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reductions in bivamelagon trial were consistent with BMI …
TopFX Expands Asset Offerings with Synthetic Indices Access
GlobeNewswire
·
July 9, 2025
Mahé, Seychelles, July 09, 2025 (GLOBE NEWSWIRE) -- TopFX has now made synthetic indices trading available to all clients through its cTrader platform, marking a turning point for those who prefer structure, speed, and simplicity in the markets. This new …
Sunny Mining launches DOGE/BTC short-term contracts, with weekly new user registrations increasing by 500%
GlobeNewswire
·
July 9, 2025
Los Angeles, California, July 09, 2025 (GLOBE NEWSWIRE) -- GlobeNewswire Sunny Mining, a global frontrunner in crypto cloud mining, with a new series of short-term DOGE and BTC cloud mining contracts, has launched these contracts which are secured with …
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium
GlobeNewswire
·
July 9, 2025
SOLANA BEACH, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …